Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Broker tips: Mitie Group, Bodycote

(Sharecast News) - RBC Capital Markets initiated coverage of facilities management firm Mitie Group on Thursday with an 'outperform' rating and 195p price target. "Mitie has aligned services with high-growth macro-trends, driving a record £33bn pipeline that feeds a £16.5bn order book, having grown circa 45% since the F2025-27E strategic plan launch," the bank said.

"We see Mitie as a good defensive play, delivering 11% earnings growth (2year-CAGR) and 5%/year shareholder returns."

RBC said forecasts indicate Mitie is on track to achieve free cash flow targets of £120m and £150m in F2026E/F2027E.

"As infill M&A remains a core priority, our forecasts suggest Mitie can invest up to circa £75m/year using FCF and available debt funding, and still remain within its target leverage range of 0.75-1.5x," the bank said.

This translates to revenue and operating profit growth of about 4% a year from acquisitions, supporting return on invested capital consistently above 20%.

RBC said its forecast of about 5% F2026 shareholder return includes a dividend payout of 30-40%, and the current £100m share buyback.

"We view Mitie as currently fundamentally undervalued, and we expect a multiple re-rating on Mitie shares as it executes on its strategic plan," it said.

Bodycote shares sparked on Thursday as Barclays upgraded its recommendation to 'overweight' from 'equalweight' and lifted its price target on the stock to 765p from 635p, saying the company was "undervalued and underappreciated".

Barclays said: "Based on end market exposure, self-help supporting margin expansion, a return to earnings per share growth, underperformance versus the sector year to date, and current valuation offering an attractive entry point, we upgrade our rating."

It also noted that FY25 should be the trough year for Bodycote and that there should be a return to organic growth in FY26.

Share this article

Related Sharecast Articles

Broker tips: Centrica, Vanquis Banking, Oxford Nanopore
(Sharecast News) - Jefferies downgraded Centrica on Monday to 'hold' from 'buy' as it pointed to a more balanced risk-reward on the stock at current trading.
Broker tips: Derwent London, Magnum Ice Cream Company
(Sharecast News) - Jefferies downgraded Derwent London to 'underperform' from 'hold' on Friday as it slashed its price target on the stock to 1,550p from 1,820p.
Broker tips: Diageo, Hiscox, Howden Joinery
(Sharecast News) - Citi cut its price target on Diageo on Thursday to 2,200p from 2,425p after the drinks giant cut its full-year guidance and halved its dividend payout a day earlier, sending shares sharply lower, after weak trading in North America and China weighed heavily.
Broker tips: Cerillion, Standard Chartered
(Sharecast News) - Analysts at Berenberg lowered their targret price on software Cerillion from 2,125p to 2,000p on Wednesday as it said the group was now "accelerating into the AI era".

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.